Oslo-based Lytix Biopharma has a new Chief Business Officer. Stephen Worsley has started at the Norwegian immune-oncology company at the beginning of September.
Dutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings.
https://european-biotechnology.com/wp-content/uploads/2024/04/AML_Auer_rods.png14401548Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-09-06 13:31:052024-04-04 16:45:54Pleco Therapeutics raises €17.3m in Series A
Synaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence.
https://european-biotechnology.com/wp-content/uploads/2024/04/EBM322_Pascal_Bricout_kl.jpg822731Maren Kühr/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngMaren Kühr2022-09-06 12:37:002024-07-16 17:42:18New Head of Finance for Carbios
https://european-biotechnology.com/wp-content/uploads/2024/04/BioEcho-Boston-_6553739_7_2022_06.jpg540960Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2022-09-02 09:34:002024-04-04 16:45:57BioEcho Life Sciences launches US subsidiary
Researchers from KU Leuven for the first time have produced human cells able to mimic the molecular mechanisms of early human embryogenesis and related defects.
Food specialist Standing Ovation SA raises €12m
Latest NewsFoodtech startup Standing Ovation SA has closed an oversubscribed €12m Series A financing round led by Astanor Ventures.
Lytix Biopharma: CBO-Position new filled
AppointmentsOslo-based Lytix Biopharma has a new Chief Business Officer. Stephen Worsley has started at the Norwegian immune-oncology company at the beginning of September.
HeartBeat.bio inks partnership with Molecular Devices
Latest NewsHeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput drug discovery screening
Mobile app recognises COVID-19 infection
Latest NewsDutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings.
Pleco Therapeutics raises €17.3m in Series A
Latest NewsDutch Pleco Therapeutics BV has raised €17.3m in a Series A financing to push its lead candidate in acute myeloid leukaemia to market approval.
Emergence Therapeutics licences Synaffix platform
Latest NewsSynaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence.
New Head of Finance for Carbios
AppointmentsFinance Expert Pascal Bricout strengthens French Carbios as Chief of Strategy; Financial Officer and a member of the Executive Committee.
Abivax SA bags €49.2m to push ABX-464
Latest NewsParis-based Abivax SA has cashed in €49.2m in an oversubscribed financing with top-tier US and European biotech investors.
BioEcho Life Sciences launches US subsidiary
Latest NewsGerman nucleic acid extraction specialist BioEcho Life Sciences has opened a subsidiary in Boston to supply the huge US-american market.
Belgian researchers create extraembryonic mesoderm cells
Latest NewsResearchers from KU Leuven for the first time have produced human cells able to mimic the molecular mechanisms of early human embryogenesis and related defects.